
|Videos|September 18, 2015
Which Medications Will Be Growth Drivers in the Industry in the Next Few Years?
Doug Long, vice president of industry relations at IMS Health, talks about which approved or pipeline drugs will be growth drivers in the industry during the next few years.
Advertisement
Doug Long, vice president of industry relations at IMS Health, talks about which approved or pipeline drugs will be growth drivers in the industry during the next few years.
This video was recorded at the 2015 NACDS Total Store Expo.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
2
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
3
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
4
Darovasertib Plus Crizotinib Shows Striking Efficacy in HLA-A2–Negative Metastatic Uveal Melanoma, OptimUM-02 Results Show
5








































































































































